Invokana has been linked to kidney damage and an increased risk in foot and leg amputation.
The Law Offices of Peter T. Nicholl is currently investigating claims from patients who suffered adverse health effects after being prescribed Invokana.
If you were prescribed Invokana and suffered a condition known as diabetic ketoacidosis, bone fractures or kidney damage, do not hesitate to contact our defective drug attorneys as soon as possible. Our Invokana lawyers have a strong history of holding negligent corporations responsible for the pain and suffering they cause.
We will provide you with a free, no obligation consultation to find out if you have an Invokana lawsuit against the drug’s manufacturer. All of our services are provided on a contingency fee basis. This means our class actions attorneys will work for you at no upfront cost and there will be no fees or costs unless we recover the compensation you deserve.
Call 410-244-7005 to find out if you have an Invokana lawsuit.
Invokana is a sodium glucose co-transporter 2 (SGLT2) developed by Mitsubishi Tanabe Pharma in 2012 and is marketed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson.
Invokana was approved by the U.S, Food and Drug Administration (FDA) in 2013, making it the first SGLT2 to be released in the U.S. The drug was marketed as an oral medication that could control blood sugar levels in adult patients with type 2 diabetes.
Patients with type 2 diabetes are resistant to insulin, which means their blood cells cannot use insulin to convert glucose into energy. This causes the body to raise its glucose levels and puts the patient at risk of suffering kidney, eye, nerve and heart damage.
Invokana works by preventing the kidneys from reabsorbing glucose and releasing it into the body’s blood stream. Instead, Invokana causes the kidneys to release excess glucose through urination.
Complete a Free Case Evaluation form.
Since Invokana was released in 2013, many patients have reported serious medical conditions to the FDA after taking the drug.
Within the first year after Invokana was released, more than 400 serious adverse health events were linked to the drug, according to the Institute of Safe Medication Practices. Some of the most serious complications associated with Invokana include:
Additionally, patients also reported severe complications such as:
However, despite these life-threatening side effects, Invokana remains one of the most commonly prescribed SGLT2 in the U.S. Additionally, Janssen Pharmaceuticals and Johnson & Johnson claim Invokana is safe for adult users with type 2 diabetes.
Call 410-244-7005 if you suffered adverse Invokana side effects.
Patients who are prescribed Invokana may be at a risk of suffering acute kidney injury, which is a sudden decrease in kidney function. This can cause dangerous levels of waste to collect in the body.
Adverse kidney function associated with Invokana may include:
If you experience acute kidney injury after taking Invokana, you should immediately contact your health care provider. However, do not stop taking Invokana without consulting with your doctor. Doing so could cause you to suffer dangerous or uncontrolled levels of glucose.
To get started, complete a Free Case Evaluation form.
Diabetic ketoacidosis is a life-threatening condition that develops when the body’s cells are unable to receive the glucose they need for energy. This occurs when there is not enough insulin in the body.
When the body’s cells do not receive enough glucose, it stays in the blood. In response, the kidneys filter out some of the glucose from the blood and excrete it through the urine. This results in fatty acids, called ketones, being released into the blood stream and can lead to a life-threatening levels of acid in the blood.
If you experience any of the following symptoms after taking Invokana, seek immediate medical attention:
Diabetic ketoacidosis is severe medical condition and must be treated in a hospital as soon as possible. The effects of diabetic ketoacidosis may increase the risk of the patient suffering coma or death.
Call 410-244-7005 to find out if you have a case.
In 2016, the Canagliflozin Cardiovascular Assessment Study (CANVAS) analyzed the side effects experienced by type 2 diabetes patients who took Invokana.
The study’s researchers found that patients who took Invokana faced a risk of foot or leg amputation two-times higher than patients who were provided a placebo.
CANVAS’s interim results have shown that using Invokana for more than one use led patients to experience increased risk of amputation with the following daily doses of Invokana:
However, only three out of every 1,000 patients who were administered a placebo during the trial experienced an increased risk of amputation.
The study found that patients who took Invokana are most at risk of suffering a leg or foot amputation, with toe amputation and metatarsal amputations being the most common.
If you are prescribed Invokana, carefully check for signs of increased tenderness, sores, ulcers and infections in your legs and feet. If you notice any adverse symptoms, immediately notify a health care provider.
Complete a Free Case Evaluation form now.
Since Invokana was first released in 2013, the FDA has released numerous warnings alerting consumers and health care providers about the dangers associated with the drug.
On May 5, 2015, the FDA released a safety alert stating Invokana and similar SGLT2s might put patients at risk of suffering ketoacidosis.
At the time, the FDA had received more than 20 reports of patients suffering ketoacidosis who were prescribed SGLT2s, including Invokana. However, as of May 2017, the FDA has received more than 70 cases of ketoacidosis between March 2013 and May 2015 from patients who used Invokana.
In December 2016, the FDA required Janssen Pharmaceuticals to change Invokana’s label to warn patients the drug could increase levels of acid in the blood. Furthermore, the updated warning labels included information that Invokana increases the risk of urinary tract infection by disposing glucose through the urinary system.
Additionally, the FDA confirmed 101 reports of patients suffering acute kidney injuries after Invokana’s release between March 2013 and October 2015. In approximately half of these cases, patients suffered kidney damage within the first month of taking Invokana. In response, the FDA strengthened its warning about the high risk of kidney damage in type 2 diabetes patients who take Invokana.
Based on the clinical data provided in the CANVAS study, the FDA issued a warning in May 2016 informing consumers that Invokana could double the risk of foot and leg amputation. In May 2017, the agency released a safety communication confirming the study’s findings in an updated warning.
Call 410-244-7005 if you were harmed after using Invokana.
Because of the adverse health risks associated with Invokana, many patients have filed Invokana lawsuits against Janssen Pharmaceuticals and Johnson & Johnson.
Many Invokana lawsuits claim Janssen Pharmaceuticals released an abnormally dangerous drug and should be held liable for placing patients at risk of life-threatening medical conditions. Additionally, several lawsuits allege that Janssen Pharmaceuticals is guilty of:
To find out if you may be entitled to file an Invokana lawsuit, our attorneys will review your use of Invokana and the adverse health events you suffered as a result. We will provide you with a free, no obligation consultation to find out if you or your loved one suffered ketoacidosis, acute kidney injury, amputation or another type of unforeseen injury that could have only occurred because of Invokana.
If we determine that you may be entitled to an Invokana lawsuit, we will work tirelessly to help you pursue the justice and compensation you deserve. All of our services are provided on a contingency fee basis, which means there will be no fees or costs unless we recover compensation for your claim. There is no risk in contacting us to discuss filing an Invokana side effects lawsuit.
Complete a Free Case Evaluation form to find out if you have a case.
Pharmaceutical corporations that fail in their obligation to provide patients quality and effective medications should be held liable for the harm they cause.
If you or someone you love has suffered acute kidney damage, ketoacidosis or another type of unforeseen injury that resulted in amputation, do not hesitate to contact the Law Offices of Peter T. Nicholl to discuss filing an Invokana lawsuit.
Our Invokana lawyers will provide you with a free, no obligation consultation to review the adverse Invokana side effects that you or your loved one has suffered. If we determine that you have a case against Janssen Pharmaceuticals, we will dedicate ourselves to helping you obtain the justice and compensation you deserve.
Call 410-244-7005 to get started today.
Contact our personal injury lawyers for a free consultation if you have been injured by another’s negligence. You may be entitled to compensation.
GET WHAT YOU DESERVE410-244-7005